Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)

About this funding opportunity

The purpose of this notice of funding opportunity (NOFO) is to provide investigators with a mechanism to request services from the state-of-the-art Biological Testing Facility that would advance their contraceptive development or reproductive health programs. This NOFO aims to position innovative and validated methods for future regulatory submission and/or clinical development. Applicants do not need to have current NIH funding to apply, but priority may be given to programs receiving NIH support at the time of application submission.

Topic areas: Life Sciences and Health.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are due May 07, 2029. Confirm the exact closing time on the official program page before applying.

Who can apply

This opportunity is open to the following applicant types:

• NGOs
• SME
• University
• Public Authorities
• Large Company
• Other

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Agency

Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) is administered by National Institutes of Health (NIH), listed via Grants.gov.